GeneQuine Biotherapeutics to Present at Arabian Tech Tour 2015 (November 2, 2015 in Jeddah, Saudi Arabia) [ 14 Oct 2015 ]

GeneQuine Biotherapeutics, developing gene therapy for joint diseases, will present at Arabian Tech Tour 2015 in Jeddah, Saudi Arabia. The Arabian Tech Tour offers a platform for high-tech companies to present their business to an invited delegation of international and local investors as well as regional high profile stakeholders.

More


GeneQuine Biotherapeutics to Present at 2015 KC Animal Health Investment Forum (September 1, 2015, Kansas City) [ 18 Aug 2015 ]

GeneQuine Biotherapeutics, developing gene therapy for joint diseases, will present at 2015 KC Animal Health Investment Forum. The KC Animal Health Investment Forum provides a unique opportunity for companies in the animal health sector to present their vision and business plan to potential investors and development Partners.

More


GeneQuine featured on LaBiotech Tour [ 29 Jun 2015 ]

Within their North German Tour LaBiotech has visited GeneQuine in Hamburg.

More


Animal Pharm publishes article on GeneQuine [ 23 Jun 2015 ]

GeneQuine was featured in Animal Pharm, a leading news website for the animal health sector.

More


GeneQuine’s CEO Interviewed at VetHealth Global 2015 Conference [ 19 Jun 2015 ]

Dr. Kilian Guse was interviewed by Canadian TV on June 8th about the VetHealth Global 2015 Conference and its importance in the Animal Health Industry.

More


GeneQuine Biotherapeutics to Present at VetHealth Global 2015 Conference (June 8-10, 2015, Prince Edward Island, Canada) [ 04 Jun 2015 ]

GeneQuine Biotherapeutics, developing gene therapy for joint diseases, will present at VetHealth Global 2015, the International Animal Health & Nutrition Business Conference

More


GeneQuine Biotherapeutics Granted Sponsor Fee Waiver by FDA [ 28 May 2015 ]

FDA grants GeneQuine Biotherapeutics a sponsor fee waiver under the significant barrier to innovation provision of ADUFA (Animal Drug User Fee Act) for FY 2015.

More


GeneQuine Biotherapeutics to Present at BioTrinity Conference (May 11-13, 2015, London) [ 04 May 2015 ]

GeneQuine Biotherapeutics, developing gene therapy for joint diseases, will present at BioTrinity 2015, Europe’s leading Biopartnering and Investment Conference, on May 13, 2015 in London.

More


Michele Sirghita Starts at GeneQuine as Communications Officer [ 01 Mar 2015 ]

Michele Sirghita, BA, has several years of working experience in the field of project management and corporate communications at international consulting and real estate companies.

More


Patent for GeneQuine’s Lead Products Granted by European Patent Office [ 26 Feb 2015 ]

A patent for GeneQuine’s lead products was granted by the European Patent Office, which represents a major milestone in securing intellectual protection in the target markets.

More